학술논문
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
Document Type
Article
Author
Source
In: Annals of Hematology . (Annals of Hematology, June 2023, 102(6):1395-1408)
Subject
Language
English
ISSN
14320584
09395555
09395555